Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:896 (10 April), doi:10.1136/bmj.328.7444.896-a
| The first 150 words of the full text of this article appear below. |
EDITORAcute stroke and transient ischaemic attacks are emergencies, and Muir in his editorial has presented recent evidence, showing that reduction of blood pressure and cholesterol, regardless of baseline values, have unequivocal benefit in secondary prevention.1
There is no real boundary between acute treatment and secondary prevention, which should start very early. This is best done in a dedicated stroke unit, to enhance the multidisciplinary approach and minimise delays, leading to better recovery.2
There is evidence that high blood glucose is detrimental after a stroke. Although exact underlying mechanisms remain unclear, evidence shows clinical worsening, with hyperglycaemia and increased risk of a second stroke with poor long term control.3
Non-fasting total homocysteine is another independent risk factor in both sexes over 60. Screening for elevated homocysteine concentrations and folate therapy may play an important part in secondary prevention. Concentrations higher than 14 µmol/l are associated with an 80% increase
Sumantra Ray, clinical research fellow
sumantra.ray{at}tuht.scot.nhs.uk
Alexander S F Doney, specialist registrar, Ronald S MacWalter, consultant physician
Stroke Studies Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY